Preferred Name |
Ulipristal Acetate |
|
Synonyms |
|
|
Definitions |
An orally bioavailable, acetate salt of ulipristal, a selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system. As a result, this agent may suppress the growth of uterine leiomyomatosis. Furthermore, by inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C91057 |
|
CAS_Registry |
126784-99-4 |
|
Chemical_Formula |
C30H37NO4 |
|
code |
C91057 |
|
Contributing_Source |
FDA |
|
definition |
An orally bioavailable, acetate salt of ulipristal, a selective progesterone receptor modulator with anti-progesterone activity. Ulipristal binds to the progesterone receptor (PR), thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system. As a result, this agent may suppress the growth of uterine leiomyomatosis. Furthermore, by inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception |
|
FDA_UNII_Code |
YF7V70N02B |
|
in_subset | ||
label |
Ulipristal Acetate |
|
NCI_Drug_Dictionary_ID |
729448 |
|
PDQ_Closed_Trial_Search_ID |
729448 |
|
PDQ_Open_Trial_Search_ID |
729448 |
|
Preferred_Name |
Ulipristal Acetate |
|
prefixIRI |
NCIT:C91057 |
|
prefLabel |
Ulipristal Acetate |
|
PubMedID_Primary_Reference |
22296076 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C2723461 |
|
subClassOf |